ReviewFrontiers in oncology2021
Tyrosine Kinase ROR1 as a Target for Anti-Cancer Therapies.
Yuming Zhao et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
67 papers cite itlatest 60 shown
this papertrialcites it
ReviewFrontiers in oncology2021
Yuming Zhao et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.